Adhesion of Blood Platelets Is Inhibited by VCL, a Recombinant Fragment (Leucine504 to Lysine728) of von Willebrand Factor

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 1, 1996, Pages 64-71

  Sixma, Jan J ^a   Ijsseldijk, Martin J W ^a   Hindriks, George ^a   Van Henrita Zanten, G ^a   Gorecki, Marian ^b   Panet, Amos ^b   Garfinkel, Leonard I ^b   De Groot, Philip G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b BioTechnology General Ltd   (Israel)

Author keywords

Adhesion; Blood platelets; Von willebrand factor

Indexed keywords

ANTITHROMBOCYTIC AGENT; BOTROCETIN; COLLAGEN; FIBRINOGEN; FIBRONECTIN; LAMININ; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN; RISTOCETIN; SNAKE VENOM; VON WILLEBRAND FACTOR; COLLAGEN TYPE 1; GLYCOPROTEIN IB; MATRIX PROTEIN;

ANIMAL; ARTERIOSCLEROSIS; ARTICLE; DRUG EFFECT; ESCHERICHIA COLI; GENETICS; HUMAN; METABOLISM; MOUSE; PATHOLOGY; THROMBOCYTE ADHESIVENESS; THROMBOCYTE AGGREGATION; VASCULAR ENDOTHELIUM; ANIMAL CELL; ATHEROSCLEROSIS; ENDOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; SHEAR RATE; THROMBOCYTE ADHESION; THROMBOGENESIS;

ANIMALS; ARTERIOSCLEROSIS; COLLAGEN; CROTALID VENOMS; ENDOTHELIUM, VASCULAR; ESCHERICHIA COLI; FIBRINOGEN; FIBRONECTINS; HUMANS; LAMININ; MICE; PEPTIDE FRAGMENTS; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RECOMBINANT PROTEINS; RISTOCETIN; VON WILLEBRAND FACTOR;

EID: 0029664355     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.1.64     Document Type: Article

References (55)

1. Roth GJ. Developing relationships: arterial platelet adhesion, glycoprotein Ib, and leucine-rich glycoproteins. Blood. 1991;77:5-19.
2. Ruggeri ZM, Ware J. The structure and function of von Willebrand factor. Thromb Haemost. 1992;67:594-599.
3. Sixma JJ, van Zanten GH, Banga JD, Nieuwenhuis HK, De Groot PG. Platelet adhesion. Semin Hematol. 1995;32:1-6.
4. Hindriks GA, IJsseldijk MJW, Sonnenberg A, Sixma JJ, De Groot PG. Platelet adhesion to laminin: role of Ca2+ and Mg2+ ions, shear rate, and platelet membrane glycoproteins. Blood. 1992;79:928-935.
5. Agbanyo FR, Sixma JJ, De Groot PG, Languino LR, Plow EF. Thrombospondin-platelet interactions: role of divalent cations, wall shear rate and platelet membrane glycoproteins. J Clin Invest. 1993;92:288-296.
6. Weiss HJ, Turitto VT, Baumgartner HR. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood: shear rate-dependent decrease of adhesion in von Willebrand disease and the Bernard-Soulier syndrome. J Lab Clin Med. 1978;92:750-764.
7. Weiss HJ, Hawiger J, Ruggeri ZM, Turitto VT, Thiagarajan R, Hoffmann T. Fibrinogen independent adhesion and thrombus formation on subendothelium mediated by GPIIb-IIIa complex at high shear rate. J Clin Invest. 1989;83:288-297.
8. Sakariassen KS, Nievelstein PFEM, Coller BS, Sixma JJ. The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium. Br J Haematol. 1986;63:681-691.
9. Turitto VT, Baumgartner HR. Platelet interaction with subendothelium in flowing rabbit blood: effect of blood shear rate. Microvase Res. 1979;17:38-54.
10. Weiss HJ, Turitto VT, Baumgartner HR. Further evidence that glycoprotein IIb-IIIa mediates platelet spreading on subendothelium. Thromb Haemost. 1991;65:202-205.
11. Baruch D, Bahnak BR, Girma J-P, Meyer D. Von Willebrand factor and platelet function. Clin Haematol. 1989;2:627-672.
12. Girma J-P, Meyer D, Verweij CL, Pannekoek H, Sixma JJ. Structure-function relationship of human von Willebrand factor. Blood. 1987;70:605-611.
13. Roth GJ, Tilani K, Hoyer LW, Hickey MJ. Localization of binding sites within human von Willebrand factor for monomeric type III collagen. Biochemistry. 1986;25:8357-8361.
14. Sobel M, Soler DF, Kermode JC, Harris RB. Localization and characterization of a heparin binding domain peptide of human von Willebrand factor. J Biol Chem. 1992;267:8857-8862.
15. Christophe O, Obert B, Meyer D, Girma J. The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin, and collagen and resides between residues Leu 512 and Lys 673. Blood. 1991;78:2310-2317.
16. Mohri H, Fujimura Y, Shima M, Yoshiok A, Houghten RA, Ruggeri ZM, Zimmerman TS. Structure of the von Willebrand factor domain interacting with glycoprotein Ib. J Biol Chem. 1988;263:17901-17904.
17. Mohri H, Yoshioka A, Zimmerman TS, Ruggeri ZM. Isolation of the von Willebrand factor domain interacting with platelet glycoprotein Ib, heparin, and collagen and characterization of its three distinct functional sites. J Biol Chem. 1989;264:17361-17367.
18. Sugimoto M, Mohri H, McClintock RA, Ruggeri ZM. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin: a model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib. J Biol Chem. 1991;266:18172-18178.
19. Berndt MC, Ward CM, Booth WJ, Castaldi PA, Mazurov AV, Andrews RK. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor: mechanism of modulation of von Willebrand factor by ristocetin and botrocetin. Biochemistry. 1992;31:11144-11151.
20. Ruoslahti E. Integrins. J Clin Invest. 1991;87:1-5.
21. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science. 1987;238:491-497.
22. Kawasaki K, Namikawa M, Murakami T, Mizuta T, Iwai Y, Hama T, Mayumi T. Amino acids and peptides, XIV: laminin related peptides and their inhibitory effect on experimental metastasis formation. Biochem Biophys Res Commun. 1991;174:1159-1162.
23. Tashiro K, Sephel GC, Weeks B, Sasaki M, Martin GR, Kleinman HK, Yamada Y. A synthetic peptide containing the IKVAV sequence from the A chain of laminin mediates cell attachment, migration, and neurite outgrowth. J Biol Chem. 1989;264:16174-16182.
24. Gralnick HR, Williams S, McKeown L, Kramer W, Krutzsch H, Gorecki M, Pinet A, Garfinkel LI. A monomeric von Willebrand factor fragment, Leu504-Lys728, inhibits von Willebrand factor interaction with glycoprotein Ib-IX. Proc Natl Acad Sci U S A. 1992;89:7880-7884.
25. Beck Y, Bartfeld D, Yavin Z, Levanon Z, Gorecki M, Hartman J. Efficient production of active human manganese Superoxide dismutase in Escherichia coli. Biotechnology. 1988;6:930-935.
26. Fischer M, Fytlovitch S, Amit B, Wortzel A, Beck Y. A constitutive expression vector system driven by the deo P1P2 promoters of Escherichia coli. Appl Microbiol Biotechnol. 1992;33:424-428.
27. Fujimura Y, Titani K, Holland LZ, Russell SR, Roberts JR, Elder JH, Ruggeri ZM, Zimmerman TS. von Willebrand factor: a reduced and alkylated 52/48 kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib. J Biol Chem. 1986;261:381-385.
28. Sakariassen KS, Aarts PAMM, De Groot PG, Houdijk WPM, Sixma JJ. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix and purified components. J Lab Clin Med. 1983;102:522-535.
29. Nievelstein PFEM, d'Alessio PA, Sixma JJ. Fibronectin in platelet adhesion to human collagen types I and III: use of nonfibrillar and fibrillar collagen in flowing blood studies. Arteriosclerosis. 1988;8:200-206.
30. van Zanten GH, De Graaf S, Slootweg PJ, Heijnen HF, Connolly TM, de Groot PG, Sixma JJ. Increased platelet deposition on atherosclerotic coronary arteries. J Clin Invest. 1994;93:615-632.
31. Van Mourik JA, Mochtar IA. Purification of human antihemophilic factor (factor VIII) by gel-chromatography. Biochim Biophys Acta. 1970;221:677-679.
32. Houdijk WPM, Sakariassen KS, Nievelstein PFEM, Sixma JJ. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar collagen types I and III. J Clin Invest. 1985;75:531-540.
33. Muggli R, Baumgartner HR, Tschopp TB, Keller H. Automated microdensitometry and protein assay as a measure for platelet adhesion and aggregation on collagen-coated slides under controlled flow conditions. J Lab Clin Med. 1980;95:195-207.
34. Berndt MC, Du X, Booth WJ. Ristocetin dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane GPIb-IX complex. Biochemistry. 1988;27:633-640.
35. Coller BS, Peerschke EI, Scudder LE, Sullivan CA. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood. 1983;61:99-110.
36. Tettero PAT, Lansdorp PM, Leeksma OC, von dem Borne AEG. Monoclonal antibodies against human platelet glycoprotein IIIa. Br J Haematol. 1983;55:509-522.
37. Stel HV, Sakariassen KS, Scholte BJ, Veerman EC, van der Kwast TH, de Groot PG, Sixma JJ, van Mourik JA. Characterization of 25 monoclonal antibodies to factor VIII-von Willebrand factor: relationship between ristocetin-induced platelet aggregation and platelet adherence to subendothelium. Blood. 1984;63:1408-1415.
38. De Groot PG, Ottenhof-Rovers M, Van Mourik JA, Sixma JJ. Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion to subendothelium is not collagen. J Clin Invest. 1988;82:65-73.
39. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest. 1973;52:2745-2756.
40. Willems C, Astaldi GCB, De Groot PG, Janssen MC, Gonsalvez MD, Zeijlemaker WP, van Mourik JA, van Aken WG. Media conditioned by cultured human vascular endothelial cells inhibit the growth of vascular smooth muscle cells. Exp Cell Res. 1982;139:191-197.
41. Sixma JJ, Nievelstein PFEM, Zwaginga JJ, De Groot PG. Adhesion of blood platelets to the extracellular matrix of cultured human endothelial cells. Ann N Y Acad Sci. 1987;516:39-51.
42. Nievelstein PFEM, De Groot PG, d'Alessio PA, Heijnen HFG, Orlando E, Sixma JJ. Platelet adhesion to vascular cells: the role of exogenous von Willebrand factor in platelet adhesion. Arteriosclerosis. 1990;10:462-469.
43. Sakariassen KS, Bolhuis PA, Sixma JJ. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium. Nature. 1979;279:635-638.
44. Connolly TM, Jacobs JW, Condra C. An inhibitor of collagenstimulated platelet activation from the salivary glands of the Haementeria officinalis leech, I: identification, isolation and characterization. J Biol Chem. 1992;267:6893-6898.
45. Keller PM, Schultz LD, Condra C, Karczewski J, Connolly TM. An inhibitor of collagen-stimulated platelet activation from the salivary glands of the Haementeria officinalis leech, II: cloning of the cDNA and expression. J Biol Chem. 1992;267:6899-6904.
46. Endenburg SC, Hantgen R, Lindeboom-Blokzijl L, Lankhof H, Jerome W, Lewis J, Sixma JJ, De Groot Ph. Thrombus formation in flowing whole blood on fibrin formed under flow conditions. Blood. In press.
47. Beumer S, Orlando E, De Groot PG, Sixma JJ. Platelet adhesion to isolated fibronectin under flow and static conditions: the contribution of glycoprotein IIb/IIIa, VLA-5 and glycoprotein Ib. Thromb Haemost. 1991;65:811. Abstract.
48. d'Alessio P, Zwaginga JJ, de Boer HC, Federici AB, Rodeghiero F, Castaman G, Mariani G, Mannucci PM, de Groot PG, Sixma JJ. Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor. Thromb Haemost. 1990;64:227-231.
49. Sixma JJ, Schiphorst ME, Verweij CL, Pannekoek H. Effect of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetin. Eur J Biochem. 1991;196:369-375.
50. Baumgartner HR, Tschopp TB, Meyer D. Shear rate dependent inhibition of platelet adhesion and aggregation on collagenous surfaces by antibodies to human factor VIII/von Willebrand factor. Br J Haematol. 1980;44:127-139.
51. Sakariassen KS, Fressinaud E, Girma JP, Baumgartner HR, Meyer D. Mediation of platelet adhesion to fibrillar collagen in flowing blood by a proteolytic fragment of human von Willebrand factor. Blood. 1986;67:1515-1518.
52. Hantgan RR, Hindriks G, Taylor R, Sixma JJ, De Groot PG. Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb:IIIa are all involved in platelet adhesion to fibrin in flowing whole blood. Blood. 1990;76:345-353.
53. Turitto VT, Weiss HJ, Zimmerman TS, Sussman II. Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion. Blood. 1985;65:823-831.
54. Sugimoto M, Ricca G, Hrinda ME, Schreiber AB, Searfoss GH, Bottini E, Ruggeri ZM. Functional modulation of the isolated glycoprotein Ib binding domain of von Willebrand factor expressed in Escherichia coli. Biochemistry. 1991;30:5202-5209.
55. Dardik R, Ruggeri ZM, Savion N, Gitel S, Martinowitz U, Chu V, Varon D. Platelet aggregation on extracellular matrix: effect of a recombinant GPIb-binding fragment of von Willebrand factor. Thromb Haemost. 1993;70:522-526.